SCHEDULE-DEPENDENT EFFICACY OF IDARUBICIN (IDA) AND DOXORUBICIN (DOX)

Citation
H. Minderman et al., SCHEDULE-DEPENDENT EFFICACY OF IDARUBICIN (IDA) AND DOXORUBICIN (DOX), Leukemia, 8(8), 1994, pp. 1401-1405
Citations number
14
Categorie Soggetti
Hematology,Oncology
Journal title
ISSN journal
08876924
Volume
8
Issue
8
Year of publication
1994
Pages
1401 - 1405
Database
ISI
SICI code
0887-6924(1994)8:8<1401:SEOI(A>2.0.ZU;2-M
Abstract
Schedule dependency of Idarubicin (Ida) and doxorubicin (Dox) toxicity was investigated in vitro using the K562 human leukemia cell line. Fo r Dox, repeated exposure to the IC30 (d x 3) resulted in comparable su rvival as single exposure to the total accumulative dose (20%). For Id a, repeated exposure to the IC30 (d x 3) decreased survival to 5%, whi le single exposure to the total accumulative dose reduced survival onl y to 20%. Total cellular accumulation of Dox was independent of schedu le of exposure, while for Ida, repeated exposure resulted in a signifi cantly higher drug accumulation compared to the single exposure to the accumulative dose. The data indicate that the schedule-dependent diff erences in cytotoxicity for the two compounds can be accounted for alm ost exclusively by an increased cellular uptake and retention of Ida w ith repeated drug exposure.